文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

遗传祖先与儿童急性淋巴细胞白血病骨骼毒性关联

Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort.
PubMed 文献 · Blood Adv · 2021-01-01

该研究对DFCI 05-001队列中449例儿童ALL患者进行基因分型与祖先分析,发现遗传定义的西班牙裔和黑人患者骨折及骨坏死风险显著更低,且低风险由非洲祖先驱动,而美洲原住民祖先比例较高者生存更差。

要点

  • 遗传定义的西班牙裔和黑人儿童ALL患者骨折与骨坏死风险显著低于其他人群。
  • 骨折和骨坏死低风险主要由非洲祖先比例驱动,而非美洲原住民或亚洲祖先。
  • 美洲原住民祖先比例较高的患者总生存和无事件生存显著更差。

核心结论

  • 黑人及西班牙裔儿童ALL患者骨骼毒性风险较低部分归因于其遗传混合中的非洲祖先比例。
  • 非洲祖先相关遗传因素可能对ALL治疗所致骨损伤具有保护作用。

研究设计与样本

  • 对DFCI 05-001队列中449例患者进行基因分型并分析遗传祖先。
  • 将临床与遗传祖先分组不一致者重新分类,未知祖先者按遗传估计重新分配。
  • 分析临床和遗传祖先与骨毒性风险及生存结局的关系。

主要发现

  • 较低风险由非洲祖先驱动,而非美洲原住民或亚洲祖先。
  • 美洲原住民祖先比例较高的患者总生存和无事件生存显著更差。

临床怎么用

  • 临床评估儿童ALL患者骨骼毒性风险时,可考虑遗传祖先背景。
  • 非洲祖先比例较高的患者可能需关注其较低的骨折和骨坏死风险。
  • 美洲原住民祖先比例较高的患者应密切监测生存结局。

局限性

  • 研究为回顾性队列分析,结果需前瞻性验证。
  • 生物学机制尚未明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hispanic children have a higher incidence of acute lymphoblastic leukemia (ALL) and inferior treatment outcomes relative to non-Hispanic White children. We previously reported that Hispanic children with ALL had lower risk of fracture and osteonecrosis. To unravel the genetic root of such ethnic differences, we genotyped 449 patients from the DFCI 05-001 cohort and analyzed their ancestry. Patients with discordant clinical and genetic ancestral groups were reclassified, and those with unknown ancestry were reassigned on the basis of genetic estimates. Both clinical and genetic ancestries were analyzed in relation to risk of bone toxicities and survival outcomes. Consistent with clinically reported race/ethnicity, genetically defined Hispanic and Black patients had significantly lower risk of fracture (Hispanic: subdistribution hazard ratio [SHR], 0.42; 95% confidence interval [CI], 0.22-0.81; P = .01; Black: SHR, 0.28; 95% CI, 0.10-0.75; P = .01), and osteonecrosis (Hispanic: SHR, 0.12; 95% CI, 0.02-0.93; P = .04; Black: SHR, 0.24; 95% CI, 0.08-0.78; P = .02). The lower risk was driven by African but not Native American or Asian ancestry. In addition, patients with a higher percentage of Native American ancestry had significantly poorer overall survival and event-free survival. Our study revealed that the lower risk of bone toxicities among Black and Hispanic children treated for ALL was attributed, in part, to the percentage of African ancestry in their genetic admixture. The findings provide suggestive evidence for the protective effects of genetic factors associated with African decent against bone damage caused by ALL treatment and clues for future studies to identify underlying biological mechanisms.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Yao S, Zhu Q, Cole PD, et al. Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort. Blood Adv. 2021. PMID: 33496737. doi:10.1182/bloodadvances.2020003060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。